This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Years of investment in digital, cloud and security strategy has helped Accenture evolve as a trusted and viable consulting services provider. It is currently the world’s top consultancy firm by revenues that increased 5% in 2019 with a contribution of 56% from consulting services.
Accenture (ACN) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Accenture's (ACN) third-quarter fiscal 2024 revenues and earnings are expected to have declined year over year.
What Analyst Projections for Key Metrics Reveal About Accenture (ACN) Q3 Earnings
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Accenture (ACN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended May 2024.
Liberty Global's (LBTYA) Acquisition to Aid Long-Term Growth
by Zacks Equity Research
Liberty Global (LBTYA) is set to acquire Formula E stakes from Warner Bros. Discovery, which is expected to aid the company's long-term prospects.
Analysts Estimate Accenture (ACN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Accenture (ACN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Accenture (ACN) Announces Completion of SOKO Acquisition
by Zacks Equity Research
SOKO becomes part of Droga5 Sao Paulo, a part of Accenture (ACN) Song, bringing with it around 300 employees.
Accenture (ACN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
The latest trading day saw Accenture (ACN) settling at $294.22, representing a +1.3% change from its previous close.
CyberArk (CYBR) Expands Customer Base With Coca-Cola HBC
by Zacks Equity Research
CyberArk (CYBR) expands its global footprint by adding Coca-Cola Hellenic Bottling Company to its identity security clientele.
Accenture (ACN) Laps the Stock Market: Here's Why
by Zacks Equity Research
In the most recent trading session, Accenture (ACN) closed at $290.43, indicating a +0.7% shift from the previous trading day.
Is Accenture (ACN) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Accenture (ACN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Accenture PLC (ACN) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Accenture (ACN). This makes it worthwhile to examine what the stock has in store.
Accenture (ACN) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
Accenture (ACN) concluded the recent trading session at $281.76, signifying a -0.19% move from its prior day's close.
Do Options Traders Know Something About Accenture (ACN) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Accenture (ACN) stock based on the movements in the options market lately.
Should You Invest in the iShares U.S. Industrials ETF (IYJ)?
by Zacks Equity Research
Sector ETF report for IYJ
Accenture (ACN) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the most recent trading session, Accenture (ACN) closed at $297.73, indicating a -1.08% shift from the previous trading day.
Why the Market Dipped But Accenture (ACN) Gained Today
by Zacks Equity Research
In the latest trading session, Accenture (ACN) closed at $307.11, marking a +1.14% move from the previous day.
Accenture (ACN) Subsidiary Completes Acquisition of Cognosante
by Zacks Equity Research
Through this acquisition, Accenture's (ACN) Accenture Federal Services is establishing a new federal health portfolio.
Accenture (ACN) to Buy OPENSTREAM HOLDINGS & Its Subsidiaries
by Zacks Equity Research
The acquisition should enhance Accenture's (ACN) capabilities in AI, cloud and smart logistics.
Accenture (ACN) Stock Moves -0.17%: What You Should Know
by Zacks Equity Research
The latest trading day saw Accenture (ACN) settling at $308, representing a -0.17% change from its previous close.
Accenture PLC (ACN) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Accenture (ACN). This makes it worthwhile to examine what the stock has in store.
Accenture (ACN) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
In the closing of the recent trading day, Accenture (ACN) stood at $306.33, denoting a -0.09% change from the preceding trading day.
Accenture (ACN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Accenture (ACN) concluded the recent trading session at $306.61, signifying a -1.72% move from its prior day's close.
Brokers Suggest Investing in Accenture (ACN): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Accenture (ACN) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Accenture (ACN) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
In the latest trading session, Accenture (ACN) closed at $303.71, marking a +1.12% move from the previous day.
Accenture PLC (ACN) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Accenture (ACN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Wall Street Bulls Look Optimistic About Accenture (ACN): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Accenture (ACN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?